BCM
BIIB icon

BTR Capital Management’s Biogen BIIB Stock Holding History

BTR Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-929
Closed -$322K – 164
2021
Q2 		$322K Buy
+929
New +$281K 0.04% 136
2014
Q3 		– Sell
-920
Closed -$290K – 134
2014
Q2 		$290K Hold
920
– – 0.08% 108
2014
Q1 		$281K Hold
920
– – 0.08% 109
2013
Q4 		$257K Hold
920
– – 0.07% 121
2013
Q3 		$221K Buy
+920
New +$206K 0.07% 128

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BTR Capital Management's BIIB Position: Q3 2021 in Review

BTR Capital Management sold out of Biogen (BIIB) in Q3 2021, closing a stake of 929 shares — an estimated $322K sold.

BTR Capital Management first reported a position in BIIB in Q3 2013 and held it in 5 quarters. The position peaked at $322K in Q2 2021. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • BTR Capital Management reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • BTR Capital Management sold 929 Biogen shares in Q3 2021, an estimated $322K.
  • BTR Capital Management first reported a position in Biogen in Q3 2013 and held it in 5 quarters.
  • BTR Capital Management's Biogen position peaked at $322K in Q2 2021.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on BTR Capital Management's 13F filing for Q3 2021, filed 18 Oct 2021.